New Delhi, March 14 Zydus Lifesciences announced on Saturday that its innovative drug has received approval from China's National Medical Products Administration (NMPA) for its Desidustat tablets, used to treat renal anemia.The company has licensed its Desidustat tablets to a subsidiary of...
china
china medical system
chronic kidney disease
ckd
desidustat
drug approval
greater china
healthcare
kidneyfailure
licensing
medical products
medicine
oxemia
patient outcomes
renal anemia
zydus lifesciences
Rajamahendravaram (Andhra Pradesh), February 24 Police on Tuesday said that a chemical coolant leak from the freezer of a milk vendor may have resulted in the death of four people here who allegedly consumed it.Four people died in the last two days after consuming the alleged contaminated...